このアイテムのアクセス数: 143

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
.jstrokecerebrovasdis.2022.106509.pdf772.34 kBAdobe PDF見る/開く
タイトル: Lack of Association between Seropositivity of Vasculopathy-Related Viruses and Moyamoya Disease
著者: Nakamura, Yasuhisa
Mineharu, Yohei  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-6346-3999 (unconfirmed)
Kamata, Takahiko
Funaki, Takeshi  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0001-9489-7469 (unconfirmed)
Miyamoto, Susumu
Koizumi, Akio
Harada, H., Kouji
著者名の別形: 峰晴, 陽平
鎌田, 貴彦
舟木, 健史
宮本, 享
小泉, 昭夫
原田, 浩二
キーワード: Moyamoya disease
Viral infection
Titer
IgG antibody
RNF213
Familial
発行日: Jul-2022
出版者: Elsevier B.V.
誌名: Journal of Stroke and Cerebrovascular Diseases
巻: 31
号: 7
論文番号: 106509
抄録: [Objectives] Although the association between genetic factors, such as RNF213 mutations, and moyamoya disease (MMD) has been well investigated, environmental factors are largely undetermined. Thus, we aimed to examine whether viral infection increases the risk of MMD. [Materials and Methods] To eliminate the effect of presence or absence of the RNF213 p.R4810K mutation, the entire study population was positive for this mutation. We collected whole blood from 111 patients with MMD (45 familial and 66 sporadic cases) and 67 healthy volunteers, and we measured the immunoglobulin G titer of 11 viruses (cytomegalovirus, varicella-zoster virus, measles virus, rubella virus, herpes simplex virus, mumps virus, Epstein–Barr virus, human parvovirus B19, human herpesvirus 6 [HHV6], human herpesvirus 8, and John Cunningham virus) that were presumed to be associated with vasculopathy using the enzyme-linked immunosorbent assay. Positivity for past viral infection was determined by cut-off values obtained from previous reports and the manufacturer's instructions, and the positive rate was compared between cases and age- and sex-matched controls. We performed familial case-specific and sporadic case-specific analyses, as well as a case–control analysis. [Results] There was no significant difference in the positive rate between the case group and the control group in any of the analyses. A significant difference was only observed in the combined case–control analysis for HHV6 (p = 0.046), but the viral antibody-positive rate in control individuals was higher than in MMD cases. [Conclusions] Our cross-sectional study suggest that the investigated 11 viruses including HHV6 are unlikely to have an impact on MMD development.
著作権等: © 2022. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
The full-text file will be made open to the public on 1 July 2023 in accordance with publisher's 'Terms and Conditions for Self-Archiving'
This is not the published version. Please cite only the published version. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。
URI: http://hdl.handle.net/2433/274190
DOI(出版社版): 10.1016/j.jstrokecerebrovasdis.2022.106509
PubMed ID: 35500358
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons